In a rather stunning turn of events, Keppel announced on 10 August 2020 that it will not be proceeding with the partial offer for Keppel Corp. Temasek’s decision to walk away outright is likely a huge negative surprise to the market as most in the street still expect the offer to proceed, albeit at a
Two significant news hit the headlines today. SG Banks dividends cap One: The Monetary Authority of Singapore (MAS) has called on locally-incorporated banks to cap their total dividends per share (DPS) for FY2020 at 60% of FY2019’s DPS and offer shareholders the option of receiving the dividends to be paid for FY2020 in scrip in
Following the insiders Insiders are the executive managers and directors who are in front of the financial and strategic decision making of their firm. Hence insider trading activity could be an informative exercise to track because their trades tell us something about the potential “undervaluation” of the stock since these insiders know their business better
Sembcorp Industries 1H20 results In this article, I provide my view on Sembcorp Industries’ latest 1H20 performance followed by some commentary pertaining to its demerger exercise with Sembcorp Marine. Sembcorp Industries announced after market hours on Friday that the Group has posted a net loss of S$131m and warns of worse to come. Sembcorp Industries
[This is an updated post for this article which was first written back in March 2020 at the peak of the COVID-19 pandemic. I will be evaluating how the 5 stocks that I have picked have performed and whether one should continue to stick with these 5 Singapore Stocks to buy. I have also added
Singapore Dividend Stocks with rock solid dividend paying track-record It is pretty rare for Singapore stocks to have a consistent track record of paying dividends. Unlike in the US where there are hundreds of companies classified as Dividend Aristocrats (companies that have increased their dividend payments for 25 consecutive years or more) and a handful
[Update: I have previously written on Biolidics back in late-April when the counter has received a lot of hype from its COVID test kit being marketed in the US. I highlighted that investing in the counter at that time has got too many variables, a key being that the sale of its COVID test kit
Hyphens Pharma: Singapore’s leading specialty pharma and consumer healthcare group Hyphens Pharma (Hyphens) is Singapore’s leading specialty pharmaceutical and consumer healthcare group. The company operates in three business segments: Specialty Pharma Principals which is the largest contributor of both revenue and earnings to the Group. The company boasts more than 30 products in its portfolio
I wrote about Sembcorp Industries and Sembcorp Marine demerging yesterday in the article below: Sembcorp Industries and Marine demerger: What you need to know and what to do In that article, I concluded that the news should be a positive one to Sembcorp Industries as the company can finally become a pure Utilities/Energy play which
Sembcorp Industries and Marine demerger The Sembcorp Group of companies finally announced that Sembcorp Industries and Sembcorp Marine will be demerged with the creation of two focused companies. There will be a proposed Sembcorp Marine Rights issue (SCM Issue) in conjunction with the demerger. I have written on both Sembcorp Marine and Sembcorp Industries several
Singapore Growth Stocks In the last article, I highlighted 5 Singapore growth stocks that the street believes will see earnings growth continuing in 2020 despite the current COVID-19 health pandemic that will undoubtedly result in many more business closures in the months ahead. Out of the 5 stocks, we have 3 from the tech sector,
Singapore Growth Stocks for consideration The current COVID-19 health pandemic has pretty much “decimated” Singapore’s economy where the latest GDP growth forecast was estimated to be at -7.0% to -4.0% for 2020. We hear of many of our favorite restaurants potentially closing down for good, according to a survey done by Chope. Amid the current
Riverstone: A beneficiary of Covid-19 Riverstone has seen a strong appreciation in its share price in the past two months, appreciating from a low of S$0.68 back in March 2020 due to t the COVID-19 driven sell-off to a high of S$1.97 last week as the company’s stellar 1Q20 performance was well above the street’s
There are a variety of ways to invest your money. A popular investment methodology popularized by various investing gurus such as Joel Greenblatt, Warren Buffett, Benjamin Graham has been the concept of Value Investing. However, value investing has significantly underperformed its growth counterpart over the last decade since GFC, with this segment continues to significantly
SIA went ex-rights today and there was some pretty weird action in its share price which I can’t seem to understand. I have previously written this article: SIA Rights Issue: Debunking the complication behind the Math. In that article, I tried to “simplify” the seemingly complicated SIA rights issue announcement and more importantly, look to
1Q20 weak performance due to COVID-19 impact Yangzijiang (YZJ) announced its 1Q20 results on 29 April. Its 1Q20 revenue declined by 44% YoY to CNY3.5bn while earnings dropped a more hefty 51% to CNY404m. At this current run-rate, annualized earnings are expected to be at CNY1.6bn compared to the street estimate of approx CNY2.8bn prior
